Additionally, the efflux transporters BCRP and MRP5, which were shown here to be regulated by Nrf2 in pancreatic cancer cells, have been implicated in resistance to gemcitabine [32,41,42]. The gene discussed is ABCG2; the disease is pancreatic neoplasm.